CLINICAL OUTCOMES OF LOW AND INTERMEDIATE RISK DIFFERENTIATED THYROID CANCER PATIENTS TREATED WITH 30MCI FOR ABLATION OR WITHOUT RADIOACTIVE IODINE THERAPY

Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy

ABSTRACT Objective To retrospectively evaluate the outcomes of patients with low and intermediate risk thyroid carcinoma treated with total thyroidectomy (TT) and who did not undergo radioiodine remnant ablation (RRA) and to compare them to patients receiving low dose of iodine (30 mCi).Subjects and methods A total of 189 differentiated thyroid can

read more

O-20 MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF HEPATITIS B VIRUS SUBGENOTYPE F1b CLUSTERS: UNRAVELING ITS ROLE IN HEPATOCARCINOGENESIS

Introduction and Objectives: Hepatitis B virus subgenotype F1b infection has been associated with the early occurrence of hepatocellular carcinoma in chronically infected patients from Alaska and Peru.In Argentina, however, despite the high prevalence of subgenotype F1b infection, this relationship has not been described.This study aimed to unravel

read more